Biotrend Cevre (Turkey) Probability of Future Stock Price Finishing Under 17.73
| BIOEN Stock | TRY 16.86 0.01 0.06% |
Biotrend |
Biotrend Cevre Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biotrend Cevre for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biotrend Cevre ve can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biotrend Cevre ve has accumulated 696.56 M in total debt with debt to equity ratio (D/E) of 2.09, implying the company greatly relies on financing operations through barrowing. Biotrend Cevre ve has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Biotrend Cevre until it has trouble settling it off, either with new capital or with free cash flow. So, Biotrend Cevre's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biotrend Cevre ve sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biotrend to invest in growth at high rates of return. When we think about Biotrend Cevre's use of debt, we should always consider it together with cash and equity. | |
| Biotrend Cevre ve has accumulated about 25.91 M in cash with (326.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2. | |
| Roughly 67.0% of Biotrend Cevre shares are held by company insiders |
Biotrend Cevre Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biotrend Stock often depends not only on the future outlook of the current and potential Biotrend Cevre's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biotrend Cevre's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 500 M |
Biotrend Cevre Technical Analysis
Biotrend Cevre's future price can be derived by breaking down and analyzing its technical indicators over time. Biotrend Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biotrend Cevre ve. In general, you should focus on analyzing Biotrend Stock price patterns and their correlations with different microeconomic environments and drivers.
Biotrend Cevre Predictive Forecast Models
Biotrend Cevre's time-series forecasting models is one of many Biotrend Cevre's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biotrend Cevre's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Biotrend Cevre ve
Checking the ongoing alerts about Biotrend Cevre for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biotrend Cevre ve help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biotrend Cevre ve has accumulated 696.56 M in total debt with debt to equity ratio (D/E) of 2.09, implying the company greatly relies on financing operations through barrowing. Biotrend Cevre ve has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Biotrend Cevre until it has trouble settling it off, either with new capital or with free cash flow. So, Biotrend Cevre's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biotrend Cevre ve sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biotrend to invest in growth at high rates of return. When we think about Biotrend Cevre's use of debt, we should always consider it together with cash and equity. | |
| Biotrend Cevre ve has accumulated about 25.91 M in cash with (326.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2. | |
| Roughly 67.0% of Biotrend Cevre shares are held by company insiders |
Other Information on Investing in Biotrend Stock
Biotrend Cevre financial ratios help investors to determine whether Biotrend Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotrend with respect to the benefits of owning Biotrend Cevre security.